MAOIs vs placebo
Dropouts due to adverse events · adults (aged 18‐85)
Comparison 3: MAOIs showed no clear difference in treatment tolerability, as measured by Dropouts due to adverse… compared with placebo (low certainty).
1 finding from 1 review
- RR 1.14 [0.9, 1.43]1 study · 37 participantsLow